Literature DB >> 16141606

The effects of culture conditions on CYP3A4 and MDR1 mRNA induction by 1alpha,25-dihydroxyvitamin D(3) in human intestinal cell lines, Caco-2 and LS180.

Tetsuya Aiba1, Mitsuru Susa, Shiro Fukumori, Yukiya Hashimoto.   

Abstract

To evaluate an in vitro model suitable for investigating intestinal first-pass drug metabolism, CYP3A4 and MDR1 mRNA induction by 1alpha,25-dihydroxyvitamin D(3) (VD3) was examined in two human intestinal cell lines, Caco-2 and LS180, under various culture conditions. CYP3A4 mRNA expression was induced by 100 nM VD3 at levels between 234-549 times above normal in Caco-2 cells for 2 weeks and by 74-200 times above normal in LS180 cells for 2 days. The CYP3A4 induction effect of 250 nM VD3 was similar to or slightly higher than that of 100 nM VD3 in both Caco-2 and LS180 cells. Also, CYP3A4 was induced in Caco-2 and LS180 cells when they were cultured on a polystyrene plate slightly less than when they were cultured on a porous membrane. The increase in fetal bovine serum (FBS) content in the culture medium resulted in little or only slight increase of CYP3A4 induction in both Caco-2 and LS180 cells. MDR1 mRNA expression was marginally increased by VD3 in LS180 cells, but not in Caco-2 cells, and neither increased FBS content nor use of a porous membrane significantly affected MDR1 induction in LS180 cells. The transepithelial electrical resistance of LS180 cells was almost zero, whereas that of Caco-2 cells was high and was marginally decreased by VD3. These findings indicate that Caco-2 cells cultured on a porous membrane with 100 nM VD3 for 2 weeks may be used as a model to investigate the intestinal absorption and first-pass metabolism of drugs, while LS180 cells may be utilized to elucidate the mechanisms which regulate intestinal CYP3A4 mRNA expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16141606     DOI: 10.2133/dmpk.20.268

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  5 in total

1.  Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study.

Authors:  Li Liu; Ann C Collier; Jeanne M Link; Karen B Domino; David A Mankoff; Janet F Eary; Charles F Spiekerman; Peng Hsiao; Anand K Deo; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2015-09-09       Impact factor: 3.922

Review 2.  Nuclear-receptor-mediated regulation of drug- and bile-acid-transporter proteins in gut and liver.

Authors:  Jeff L Staudinger; Sarah Woody; Mengxi Sun; Wenqi Cui
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

3.  Curdione Plays an Important Role in the Inhibitory Effect of Curcuma aromatica on CYP3A4 in Caco-2 Cells.

Authors:  Xiao-Long Hou; Emi Hayashi-Nakamura; Tomoka Takatani-Nakase; Ken Tanaka; Kyoko Takahashi; Katsuko Komatsu; Koichi Takahashi
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-13       Impact factor: 2.629

4.  Establishment of a novel culture method for maintaining intestinal stem cells derived from human induced pluripotent stem cells.

Authors:  Satoshi Kondo; Shota Mizuno; Tadahiro Hashita; Takahiro Iwao; Tamihide Matsunaga
Journal:  Biol Open       Date:  2020-01-09       Impact factor: 2.422

5.  Pulchinenosides from Pulsatilla Chinensis Increase P-Glycoprotein Activity and Induce P-Glycoprotein Expression.

Authors:  Yali Liu; Ling Zhang; Shaofeng Wei; Jinyang Cai; Zhenzhong Zang; Meng Wang; Dan Su; Phillip M Gerk
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-18       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.